When a drug blocks reuptake or breakdown of a neurotransmitter by the action of enzymes, the drug is acting as an

SNRI- Selective neurotransmitter reuptake inhibitor. Drugs that have use this mechanism of operation can increase the presence of the targeted neurotransmitter in a subject as more of the neurotransmitter remains freely available. This class of drugs is commonly used in the treatment of depression and other maladies where neurotransmitter levels can affect subject outcomes.

Brother ur in collage do it yourself or i will tell prof. mike